Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The corticosteroid budesonide and the long-acting beta2-adrenoceptor agonist formoterol have been combined into a single pressurized metered–dose inhaler (pMDI). The combination pMDI improves lung function, asthma control, asthma symptoms and asthma–related quality of life outcomes in patients with persistent asthma that is mild to moderate or moderate to severe.


Today in Pulmonology...keeping you current

Management of H1N1 influenza virus respiratory syndrome
Minerva Anestesiologica, 11/11/09

Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: A meta-analysis of randomized controlled trials
Journal of Critical Care, 11/11/09

An Umbrella Review: Corticosteroid Therapy for Adults with Acute Asthma
American Journal of Medicine, 10/27/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address